SCHEMBL20564407

SCHEMBL20564407

NOCc1ccccc1.O=C(Oc1ccc([N+](=O)[O-])cc1)Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.62
RAB9A P51151 2/20 0.54
NPC1 O15118 1/20 0.54
HTR2A P28223 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.52
ALDH1A1 P00352 3/20 0.49
LMNA P02545 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
HTT P42858 1/20 0.49
BCL9 O00512 1/20 0.47
CTNNB1 P35222 1/20 0.47
MAPT P10636 1/20 0.46
AGXT P21549 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1714950 0.86 HTR2A (0.70) RAB9ANPC1HTR2ASMN1; SMN2ALDH1A1
SCHEMBL20377184 0.83 SMN1; SMN2 (0.64) SMN1; SMN2ALDH1A1LMNABCL9CTNNB1
SCHEMBL6322393 0.83 SMN1; SMN2 (0.64) SMN1; SMN2ALDH1A1LMNABCL9CTNNB1
SCHEMBL7440434 0.83 HTR2A (0.53) RAB9ANPC1HTR2ASMN1; SMN2ALDH1A1
SCHEMBL16695904 0.83 HTR2A (0.56) RAB9ANPC1HTR2ASMN1; SMN2ALDH1A1
SCHEMBL27189134 0.80 HTR2A (0.59) RAB9ANPC1HTR2ASMN1; SMN2ALDH1A1
SCHEMBL14437515 0.80 HTR2A (0.66) RAB9AHTR2ASMN1; SMN2ALDH1A1LMNA
SCHEMBL4644851 0.80 HTR2A (0.56) RAB9ANPC1HTR2ASMN1; SMN2ALDH1A1
SCHEMBL26374 0.80 GAA (0.65) RAB9ANPC1HTR2ASMN1; SMN2ALDH1A1
SCHEMBL17022709 0.79 POLB (0.63) SMN1; SMN2ALDH1A1LMNABCL9CTNNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3625209-A1 BIS-OCTAHYDROPHENANTHRENE CARBOXAMIDES AND PROTEIN CONJUGATES THEREOF Regeneron Pharmaceuticals, Inc. (US) 2020-03-25 EP disclosed
WO-2018213082-A1 BIS-OCTAHYDROPHENANTHRENE CARBOXAMIDES AND PROTEIN CONJUGATES THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2018-11-22 WO disclosed